Catalent Biologics announces new advisory board Catalent Biologics announces new advisory board It has diverse expertise in biologics development and commercialisation New generation takes over at Romaco Innojet New generation takes over at Romaco Innojet Zeljko Pockaj becomes Managing Director Bionomics strengthens management team Bionomics strengthens management team Appoints Tony Colasin as US-based Chief Business Officer Quotient Clinical’s Chief Scientific Officer awarded honorary professorship at the University of Nottingham Quotient Clinical’s Chief Scientific Officer awarded honorary professorship at the University of Nottingham Dr Peter Scholes spent six years studying at the University Dr Jan Wren joins SafeBridge Europe Dr Jan Wren joins SafeBridge Europe Brings more than 20 years' experience at GSK to the position Brian Hilberdink promoted to President of Novo Nordisk Canada Brian Hilberdink promoted to President of Novo Nordisk Canada He has been with the Denmark-headquartered insulin specialist for 20 years Bruce Seeley joins CTI BioPharma as EVP and Chief Commercial Officer Bruce Seeley joins CTI BioPharma as EVP and Chief Commercial Officer Brings more than 25 years of relevant experience to the position Intrexon adds three to executive team Intrexon adds three to executive team In Communications, Finance and Head of the Health Sector Baxalta appoints Jacopo Leonardi as EVP and President Immunology Baxalta appoints Jacopo Leonardi as EVP and President Immunology Biopharmaceutical firm specialises in developing and manufacturing plasma-based therapies for rare diseases Novogen appoints Iain Ross as acting CEO Novogen appoints Iain Ross as acting CEO Dr Graham Kelly has decided to leave the company to resume non-oncology based early stage research BioClinica expands eClinical leadership team BioClinica expands eClinical leadership team Andrew Masters and Angelo Stortini take key roles in the eClinical solutions team Richard Torbett to join ABPI Richard Torbett to join ABPI To lead the commercial team as Executive Director – Commercial UK PCI welcomes Dr Tadataka Yamada to Board of Directors PCI welcomes Dr Tadataka Yamada to Board of Directors Formerly Head of R&D at Takeda and GlaxoSmithKline Dr Ursel Nait joins regulatory specialist Diapharm Dr Ursel Nait joins regulatory specialist Diapharm She has been named Senior Manager GMP Services at the German firm Pharmatech appoints Krystyna Kowalczyk as Chief Operating Officer Pharmatech appoints Krystyna Kowalczyk as Chief Operating Officer To further enhance the company's expertise in clinical oncology trials Mission Therapeutics adds Dr Colin Goddard to its Board of Directors Mission Therapeutics adds Dr Colin Goddard to its Board of Directors He was formerly Chief Executive of OSI Pharmaceuticals